Cargando…
Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma
BACKGROUND: Platelet-derived growth factor receptor alpha (PDGFRA) is the second most frequently mutated tyrosine kinase receptor in glioblastoma (GBM). However, the prognostic impact of PDGFRA amplification on GBM patients remains unclear. Herein, we evaluated this impact by retrospectively analyzi...
Autores principales: | Higa, Nayuta, Akahane, Toshiaki, Yokoyama, Seiya, Yonezawa, Hajime, Uchida, Hiroyuki, Takajo, Tomoko, Otsuji, Ryosuke, Hamada, Taiji, Matsuo, Kei, Kirishima, Mari, Hata, Nobuhiro, Hanaya, Ryosuke, Tanimoto, Akihide, Yoshimoto, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332894/ https://www.ncbi.nlm.nih.gov/pubmed/35911637 http://dx.doi.org/10.1093/noajnl/vdac097 |
Ejemplares similares
-
Distribution and favorable prognostic implication of genomic
EGFR
alterations in
IDH
‐wildtype glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2022) -
Alterations in EGFR and PDGFRA are associated with the localization of contrast-enhancing lesions in glioblastoma
por: Makino, Ryutaro, et al.
Publicado: (2023) -
Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2023) -
A tailored next‐generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas
por: Higa, Nayuta, et al.
Publicado: (2020) -
Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel
por: HIGA, Nayuta, et al.
Publicado: (2022)